An Open Label Study in Healthy Volunteers to Evaluate the Potential for Drug/Drug Interactions Between F901318 and Fluconazole
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2017
At a glance
- Drugs F 901318 (Primary) ; Fluconazole
- Indications Aspergillosis
- Focus Adverse reactions
- Sponsors F2G
- 01 Feb 2017 Status changed from recruiting to completed.
- 08 Jun 2016 Status changed from not yet recruiting to recruiting.
- 13 Apr 2016 New trial record